Complete Genomics greenshoe exercised in $79.06 million stock offering

Shares sold at $12.50 apiece through bookrunners Jefferies, UBS

By Devika Patel

Knoxville, Tenn., June 1 - Complete Genomics, Inc. said it sold $79.06 million of common stock in a public offering. The deal priced for $68.75 million with a $10.31 million over-allotment option, which was fully exercised on May 26.

The company sold 6,325,000 common shares at $12.50 apiece. Of the shares, 825,000 were part of the fully exercised greenshoe. The price per share is a 6.16% discount to the company's $13.32 closing share price on May 25.

Jefferies & Co., Inc. and UBS Investment Bank were the bookrunners. Baird and Cowen & Co. were co-managers.

Mountain View, Calif.-based Complete Genomics makes a DNA sequencing platform for human genome sequencing and analysis.

Issuer:	Complete Genomics, Inc.
Issue:	Common shares
Amount:	$79,062,500 (including $10,312,500 greenshoe)
Shares:	6,325,000
Price:	$12.50
Warrants:	No
Agents:	Jefferies & Co., Inc., UBS Investment Bank (bookrunners), Baird, Cowen & Co. (co-managers)
Pricing date:	May 26
Settlement date:	June 1
Stock symbol:	Nasdaq: GNOM
Stock price:	$13.32 at close May 25
Market capitalization:	$438.03 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.